Announcement on Entrusted Financial Management in Q4 2025
Filed with SSE · · 6 pages · Chinese
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Obtaining Drug Registration Certificate for Bupivacaine Hydrochloride Injection
- Announcement on Provision of Online Voting Reminder Service for General Meeting
- Announcement on Early Release of Pledge and Pledge of Shareholders' Shares
- Announcement on Completion of Execution of Reorganization Plan of Aoyuan Beauty Valley Technology Co., Ltd., in Which the Wholly-owned Subsidiary Participated as a Reorganization Investor
Later from Jointown Pharmaceutical
- Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation Bonds
- Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of Association
- Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets
- Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert
- Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation Bonds
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical